1. Thymidine kinase 1 through the ages: a comprehensive review
   Eliza E. Bitter et al, 2020, Cell & Bioscience CrossRef
2. Plasma thymidine kinase 1 activity and outcome of ER+ HER2− metastatic breast cancer patients treated with palbociclib and endocrine therapy
   Luc Cabel et al, 2020, Breast Cancer Research CrossRef
3. Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer
   A. Matikas et al, 2021, ESMO Open CrossRef
4. E2F1 downregulation by arsenic trioxide in lung adenocarcinoma
   SZE-KWAN LAM et al, 2014, International Journal of Oncology CrossRef
5. Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor–positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT)
   Amelia McCartney et al, 2019, European Journal of Cancer CrossRef
6. The assay and clinical significance of serum thymidine kinase 1 in patients with colorectal carcinoma
   Y. Zhang et al, 2015, European Surgery CrossRef
7. Generation and Application of Polyclonal Igy Antibodies Specific for Full-Length and Nicked Prostate-Specific Antigen
   Agnieszka Łupicka-Słowik et al, 2014, Bioanalysis CrossRef
8. Serum Thymidine Kinase 1 Activity in Solid Tumor (Breast and Colorectal Cancer) Patients Treated With Adjuvant Chemotherapy
   M. Bolayirli et al, 2013, Journal of Clinical Laboratory Analysis CrossRef